Olanzapine trials for Schizophrenia

All Olanzapine trials · All Schizophrenia trials

Phase breakdown

Recruiting trials studying Olanzapine for Schizophrenia

• "Extended" (Alternate Day) Antipsychotic Dosing
  NCT04478838 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients
  NCT05669742 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
  NCT07565428 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 13 locations
• Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
  NCT05303064 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · 47 locations

Common questions

How many trials study Olanzapine for Schizophrenia?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.